Jm. Idiculla et al., Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and alpha-subunit, ANN CLIN BI, 38, 2001, pp. 566-571
A 44-year-old woman presented to her GP with excessive tiredness. She had p
ositive thyroid microsomal and thyroglobulin autoantibodies and was found t
o have an elevated serum thyroid-stimulating hormone (TSH) concentration of
8.37 (normal =0.15-3.5) mU/L and a low normal total thyroxine (T-4) of 86
(reference range 60-145)nmol/L. She was rendered symptom free on a dose of
150 mug of thyroxine per day. However, her TSH failed to return to normal,
and following a further increase in her thyroxine dose she was referred to
the endocrine clinic for further assessment. Her TSH at this stage was 14mU
/L, free T-4 (fT(4)) 28 (normal= 10-27)pmol/L and free T-3 (fT(3)) 10 (norm
al=4.3-7.6)pmol/L. She denied any problems with adherence to her medication
. Her serum prolactin was elevated at 861 (normal= 60-390)mU/L. A pituitary
tumour was suspected and an MRI scan showed a macroadenoma of the right lo
be of the pituitary, extending into the suprasellar cistern. The tumour was
resected trans-sphenoidally. Electron microscopy showed a dual population
of neoplastic cells compatible with a thyrotroph cell and prolactin-secreti
ng adenoma. Immunocytochemistry and cell culture studies confirmed the secr
etion of TSH, prolactin and a-subunit. Postoperative combined anterior pitu
itary function tests did not demonstrate any deficiency of anterior pituita
ry hormones. A repeat MRI scan showed no significant residual tumour; howev
er, her serum TSH and prolactin levels remained high and she was given a co
urse of pituitary irradiation. This case illustrates the difficulty of diag
nosing a TSHoma when it coexists with autoimmune hypothyroidism. We believe
the combination of pathologies reported here is unique.